Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
428
-
Total 13F shares, excl. options
-
19.8M
-
Shares change
-
+1.3M
-
Total reported value, excl. options
-
$5.41B
-
Value change
-
+$314M
-
Put/Call ratio
-
1.61
-
Number of buys
-
179
-
Number of sells
-
-255
-
Price
-
$273.11
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2024
520 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2024.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 428 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.8M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.37M shares), BlackRock Inc. (1.55M shares), Veritas Asset Management LLP (1.13M shares), STATE STREET CORP (860K shares), VAN ECK ASSOCIATES CORP (659K shares), Select Equity Group, L.P. (650K shares), First Eagle Investment Management, LLC (636K shares), EARNEST PARTNERS LLC (607K shares), Invesco Ltd. (548K shares), and DIMENSIONAL FUND ADVISORS LP (495K shares).
This table shows the top 428 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.